These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36274464)

  • 1. The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction.
    Griem-Krey N; Gauger SJ; Gowing EK; Thiesen L; Frølund B; Clarkson AN; Wellendorph P
    Biomed Pharmacother; 2022 Dec; 156():113895. PubMed ID: 36274464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.
    Leurs U; Klein AB; McSpadden ED; Griem-Krey N; Solbak SMØ; Houlton J; Villumsen IS; Vogensen SB; Hamborg L; Gauger SJ; Palmelund LB; Larsen ASG; Shehata MA; Kelstrup CD; Olsen JV; Bach A; Burnie RO; Kerr DS; Gowing EK; Teurlings SMW; Chi CC; Gee CL; Frølund B; Kornum BR; van Woerden GM; Clausen RP; Kuriyan J; Clarkson AN; Wellendorph P
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIα.
    Griem-Krey N; Klein AB; Clausen BH; Namini MR; Nielsen PV; Bhuiyan M; Nagaraja RY; De Silva TM; Sobey CG; Cheng HC; Orset C; Vivien D; Lambertsen KL; Clarkson AN; Wellendorph P
    J Cereb Blood Flow Metab; 2023 Aug; 43(8):1419-1434. PubMed ID: 37026450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain.
    Tian Y; Shehata MA; Gauger SJ; Veronesi C; Hamborg L; Thiesen L; Bruus-Jensen J; Royssen JS; Leurs U; Larsen ASG; Krall J; Solbak SMØ; Wellendorph P; Frølund B
    J Med Chem; 2022 Nov; 65(22):15066-15084. PubMed ID: 36346645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKIIα as a Promising Drug Target for Ischemic Grey Matter.
    Griem-Krey N; Clarkson AN; Wellendorph P
    Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GHB receptor targets in the CNS: focus on high-affinity binding sites.
    Bay T; Eghorn LF; Klein AB; Wellendorph P
    Biochem Pharmacol; 2014 Jan; 87(2):220-8. PubMed ID: 24269284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain.
    Wellendorph P; Høg S; Greenwood JR; de Lichtenberg A; Nielsen B; Frølund B; Brehm L; Clausen RP; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2005 Oct; 315(1):346-51. PubMed ID: 16014570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective post-insult neuroprotection by a novel Ca(2+)/ calmodulin-dependent protein kinase II (CaMKII) inhibitor.
    Vest RS; O'Leary H; Coultrap SJ; Kindy MS; Bayer KU
    J Biol Chem; 2010 Jul; 285(27):20675-82. PubMed ID: 20424167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain.
    Baucum AJ; Shonesy BC; Rose KL; Colbran RJ
    ACS Chem Neurosci; 2015 Apr; 6(4):615-31. PubMed ID: 25650780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1.
    Thiesen L; Kehler J; Clausen RP; Frølund B; Bundgaard C; Wellendorph P
    J Pharmacol Exp Ther; 2015 Aug; 354(2):166-74. PubMed ID: 25986445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain.
    Tian Y; Shehata MA; Gauger SJ; Ng CKL; Solbak S; Thiesen L; Bruus-Jensen J; Krall J; Bundgaard C; Gibson KM; Wellendorph P; Frølund B
    J Med Chem; 2022 May; 65(9):6656-6676. PubMed ID: 35500061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CaMKIIα holoenzyme stability.
    Torres-Ocampo AP; Özden C; Hommer A; Gardella A; Lapinskas E; Samkutty A; Esposito E; Garman SC; Stratton MM
    Protein Sci; 2020 Jun; 29(6):1524-1534. PubMed ID: 32282091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways.
    Tang Q; Ke H; Wu C; Zeng J; Li Z; Liu Y; Feng S; Xue Q; Xu X
    J Ethnopharmacol; 2019 Jul; 239():111925. PubMed ID: 31055001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using
    Klein AB; Bay T; Villumsen IS; Falk-Petersen CB; Marek A; Frølund B; Clausen RP; Hansen HD; Knudsen GM; Wellendorph P
    Neurochem Int; 2016 Nov; 100():138-145. PubMed ID: 27615059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational spread drives the evolution of the calcium-calmodulin protein kinase II.
    Khan S
    Sci Rep; 2022 May; 12(1):8499. PubMed ID: 35589775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+/CaM dependent protein kinase II (CaMKII)α and CaMKIIβ hub domains adopt distinct oligomeric states and stabilities.
    Özden C; MacManus S; Adafia R; Samkutty A; Torres-Ocampo AP; Garman SC; Stratton MM
    Protein Sci; 2024 Apr; 33(4):e4960. PubMed ID: 38501502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated CaMKII
    Marks CR; Shonesy BC; Wang X; Stephenson JR; Niswender CM; Colbran RJ
    Mol Pharmacol; 2018 Dec; 94(6):1352-1362. PubMed ID: 30282777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakage of the oligomeric CaMKII hub by the regulatory segment of the kinase.
    Karandur D; Bhattacharyya M; Xia Z; Lee YK; Muratcioglu S; McAffee D; McSpadden ED; Qiu B; Groves JT; Williams ER; Kuriyan J
    Elife; 2020 Sep; 9():. PubMed ID: 32902386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin.
    Robison AJ; Bartlett RK; Bass MA; Colbran RJ
    J Biol Chem; 2005 Nov; 280(47):39316-23. PubMed ID: 16172120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.